MDI Biological Laboratory

Muscular Dystrophy (MD) affects ~250,000 individuals in the United States and is a debilitating group of diseases characterized by progressive skeletal muscle degeneration (1). Individuals with mutations in a gene required for dystroglycan glycosylation, GDP-mannose pyrophosphorylase B (GMPPB), clinically present variable MD phenotypes and ages ... ................
................